|Articles|August 1, 1998

Supplements and Featured Publications

  • Predicting the Probability of Achieving NCEP LDL-C Treatment Goals Using HMG-CoA Reductase Inhibitor
  • Volume 4
  • Issue 8 Suppl

CME / CPE Quiz

Articles in this issue

over 27 years ago

Participating Faculty

over 27 years ago

Predicting the Probability of Achieving NCEP LDL-C Treatment Goals Using HMG-CoA Reductase Inhibitor Monotherapy

over 27 years ago

Selected Abstracts

over 27 years ago

Bibliography

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs
Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

View more
Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care
AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

View more
Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text